Skip to main content
SpringerLink
Log in

Procedural Treatments: Surgery in End-Stage Glaucoma

  • Chapter
  • First Online:
Pearls of Glaucoma Management

Abstract

End-stage glaucoma is a term used to describe glaucoma that has reached a stage of extreme or near total-vision loss; however, there is no universally accepted formal definition. One definition implies that patients with end-stage glaucoma have a very constricted visual field, less than 10o in diameter [1]. According to the Advanced Glaucoma Intervention Study (AGIS) an AGIS visual field score of 17–20 classifies an eye as having end-stage glaucoma [2]. Others define ­end-stage glaucoma based on a visual acuity (VA) of 20/200 or worse that is attributable to glaucoma [3].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Gillies WE, Brooks AM, Strang NT (2000) Management and prognosis of end stage glaucoma. Clin Experiment Ophthalmol 28:405–408.

    Article  PubMed  CAS  Google Scholar 

  2. The Advanced Glaucoma Intervention Study Investigators (1994) Advanced Glaucoma Intervention Study: 2. Visual field test scoring and reliability. Ophthalmology 101:1445–1455.

    Google Scholar 

  3. Mills RP, Budenz DL, Lee PP, et al (2006) Categorizing the stage of glaucoma from pre-diagnosis to end-stage disease. Am J Ophthalmol 141:24–30.

    Article  PubMed  Google Scholar 

  4. Law SK, Nguyen AM, Coleman AL, et al (2007) Severe loss of central vision in patients with advanced glaucoma undergoing trabeculectomy. Arch Ophthalmol 125:1044–1050.

    Article  PubMed  Google Scholar 

  5. Iester M, Zingirian M (2002) Quality of life in patients with early, moderate and advanced glaucoma. Eye 16:44–49.

    Article  PubMed  CAS  Google Scholar 

  6. Zalta AH (1991) Use of a central 10 degrees field and size V stimulus to evaluate and monitor small central islands of vision in end stage glaucoma. Br J Ophthalmol 75:151–154.

    Article  PubMed  CAS  Google Scholar 

  7. The AGIS Investigators (2004) The Advanced Glaucoma Intervention Study (AGIS): 14. Distinguishing progression of glaucoma from visual field fluctuations. Ophthalmology 111:2109–2116.

    Google Scholar 

  8. Bartz-Schmidt KU, Thumann G, Jonescu-Cuypers CP, et al (1999) Quantitative morphologic and functional evaluation of the optic nerve head in chronic open-angle glaucoma. Surv Ophthalmol 44(Suppl 1):S41–S53.

    Article  Google Scholar 

  9. Lichter PR, Musch DC, Gillespie BW, et al (2001) Interim clinical outcomes in The Collaborative Initial Glaucoma Treatment Study. Comparing initial treatment randomized to medications or surgery. Ophthalmology 108:1943–1953.

    Article  PubMed  CAS  Google Scholar 

  10. Heijl A, Leske MC, Bengtsson B, et al.; Early Manifest Glaucoma Trial Group. (2002) Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 120:1268–1279.

    Google Scholar 

  11. Caprioli J (2007) Intraocular pressure fluctuation: an independent risk factor for glaucoma? Arch Ophthalmol 125: 1124–1125.

    Article  PubMed  Google Scholar 

  12. Morgan W (2000) End stage glaucoma: fortunately the end may be far off. Clin Experiment Ophthalmol 28:397.

    Article  PubMed  CAS  Google Scholar 

  13. Gedde SJ, Schiffman JC, Feuer WJ, et al (2007) Treatment outcomes in the tube versus trabeculectomy study after one year of follow-up. Am J Ophthalmol 143:9–22.

    Article  PubMed  Google Scholar 

  14. Viswanathan AC, McNaught AI, Poinoosawmy D, et al (1999) Severity and stability of glaucoma: patient perception compared with objective measurement. Arch Ophthalmol 117:450–454.

    Article  PubMed  CAS  Google Scholar 

  15. Malerbi FK, Hatanaka M, Vessani RM, et al (2005) Intraocular pressure variability in patients who reached target intraocular pressure. Br J Ophthalmol 89:540–542.

    Article  PubMed  CAS  Google Scholar 

  16. The AGIS Investigators (2000) The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 130:429–440.

    Google Scholar 

  17. Nouri-Mahdavi K, Hoffman D, Coleman AL, et al.; Advanced Glaucoma Intervention Study (2004) Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology 111:1627–1635.

    Google Scholar 

  18. Collaer N, Zeyen T, Caprioli J (2005) Sequential office ­pressure measurements in the management of glaucoma. ­­J Glaucoma 14:196–200.

    Article  PubMed  Google Scholar 

  19. Bergea B, Bodin L, Svedbergh B (1999) Impact of intraocular pressure regulation on visual fields in open-angle glaucoma. Ophthalmology 106:997–1005.

    Article  CAS  Google Scholar 

  20. O’Brien C, Schwartz B, Takamoto T, et al (1991) Intraocular pressure and the rate of visual field loss in chronic open-angle glaucoma. Am J Ophthalmol 111:491–500.

    PubMed  Google Scholar 

  21. Stewart WC, Kolker AE, Sharpe ED, et al (2000) Factors associated with long-term progression or stability in primary open-angle glaucoma. Am J Ophthalmol 130:274–279.

    Article  PubMed  CAS  Google Scholar 

  22. Lichter P (2003) Intraocular pressure fluctuation is a risk factor for visual loss in glaucoma patients. Paper presented at American Academy of Ophthalmology Annual Meeting; November 18, Anaheim, CA.

    Google Scholar 

  23. Lee PP (2006) Association between IOP fluctuation and glaucoma progression. Paper presented at American Glaucoma Society 2006 Annual Meeting; March 3, Charleston, SC.

    Google Scholar 

  24. Bengtsson B, Leske MC, Hyman L, et al (2007) Fluctuation of intraocular pressure and glaucoma progression in the Early Manifest Glaucoma Trial. Ophthalmology 114:205–209.

    Article  PubMed  Google Scholar 

  25. Ocular Hypertension Treatment Study Group; European Glaucoma Prevention Study Group; Gordon MO, et al. (2007) Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension. Ophthalmology 114:10–19.

    Google Scholar 

  26. Konstas A, Topouzis F, Leliopoulou O, et al (2006) 24-Hour intraocular pressure control with maximum medical therapy compared with surgery in patients with advanced open-angle glaucoma. Ophthalmology 113:761–765.

    Article  PubMed  Google Scholar 

  27. Medeiros FA, Pinheiro A, Moura FC, et al (2002) Intraoc­ular pressure fluctuations in medical versus surgically treated glaucomatous patients. J Ocul Pharmacol Ther 18: 489–498.

    Article  CAS  Google Scholar 

  28. Souza C, Tran DH, Loman J, et al (2007) Long-term outcomes of Ahmed glaucoma valve implantation in refractory glaucomas. Am J Ophthalmol 144:893–900.

    Article  Google Scholar 

  29. Baudouin C, Liang H, Hamard P, et al (2008) The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-Helper 1 and T-Helper 2 pathways. Ophthalmology 115:109–115.

    Article  PubMed  Google Scholar 

  30. Broadway DC, Grierson I, O’Brien C, et al (1994) Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. Arch Ophthalmol 112:1446–1454.

    Article  PubMed  CAS  Google Scholar 

  31. Broadway DC, Grierson I, Sturmer J, et al (1996) Reversal of topical antiglaucoma medication effects on the conjunctiva. Arch Ophthalmol 114:262–267.

    Article  PubMed  CAS  Google Scholar 

  32. Kim YY, Sexton RM, Shin DH, et al (1998) Outcomes of primary phakic trabeculectomies without versus with 0.5- to 1-minute versus 3- to 5-minute mitomicin C. Am J Ophthal­mol 126:755–762.

    Article  CAS  Google Scholar 

  33. Kupin TH, Juzych MS, Shin DH, et al (1995) Adjunctive mitomycin C in primary trabeculectomy in phakic eyes. Am J Ophthalmol 119:30–39.

    PubMed  CAS  Google Scholar 

  34. Bindlish R, Condon G, Schlosser J, et al (2002) Efficacy and safety of mitomycin-C in primary trabeculectomy. Five-year follow-up. Ophthalmology 109:1336–1342.

    Article  PubMed  Google Scholar 

  35. Wilkins M, Indar A, Wormald R (2005) Intra-operative mitomycin C for glaucoma surgery. Cochrane Database Syst Rev (4):CD002897.

    Google Scholar 

  36. Schwartz K, Budenz D (2004) Current management of glaucoma. Curr Opin Ophthalmol 15:119–126.

    Article  PubMed  Google Scholar 

  37. Ceballos EM, Parrish RK II, Schiffman JC (2002) Outcome of Baerveldt glaucoma drainage implants for the treatment of uveitic glaucoma. Ophthalmology 109:2256–2260.

    Article  PubMed  Google Scholar 

  38. Wilson MR, Mendis U, Smith SD, et al (2000) Ahmed glaucoma valve implant vs trabeculectomy in the surgical treatment of glaucoma: a randomized clinical trial. Am J Ophthalmol 130:267–273.

    Article  PubMed  CAS  Google Scholar 

  39. Netland PA; Ophthalmic Technology Assessment Committee Glaucoma Panel, American Academy of Ophthalmology (2001) Nonpenetrating glaucoma surgery. Ophthalmology 108:416–421.

    Google Scholar 

  40. Sarodia U, Shaarawy T, Barton K (2007) Nonpenetrating glaucoma surgery: a critical evaluation. Curr Opin Ophthalmol 18:152–158.

    Article  PubMed  Google Scholar 

  41. Wilson MR (2001) A new role for diode laser transscleral cyclophotocoagulation? Arch Ophthalmol 119:424–425.

    PubMed  CAS  Google Scholar 

  42. Ulbig MW, McHugh DA, McNaught AI, et al (1995) Clinical comparison of semiconductor diode versus neodymium: YAG non-contact cyclo photocoagulation. Br J Ophthalmol 79:569–574.

    Article  PubMed  CAS  Google Scholar 

  43. Ulbig MW, McHugh DA, McNaught AI, et al (1994) Contact diode laser cyclo-photocoagulation for refractory glaucoma. A pilot study. Ger J Ophthalmol 3:212–215.

    PubMed  CAS  Google Scholar 

  44. Egbert P, Fiadoyor S, Budenz D, et al (2001) Diode laser transscleral cyclophotocoagulation as a primary surgical treatment for primary open-angle glaucoma. Arch Ophthalmol 119:345–350.

    PubMed  CAS  Google Scholar 

  45. Grueb M, Rohrbach JM, Bartz-Schmidt KU, et al (2006) Transscleral diode laser cyclophotocoagulation as primary and secondary surgical treatment in primary open-angle and pseudoexfoliative glaucoma. Long-term clinical outcomes. Graefe’s Arch Clin Exp Ophthalmol 244:1293–1299.

    Article  Google Scholar 

  46. Lai JS, Tham CC, Chan JC, et al (2005) Diode laser transscleral cyclophotocoagulation as primary surgical treatment for medically uncontrolled chronic angle-closure glaucoma: long-term clinical outcomes. J Glaucoma 14:114–119.

    Article  PubMed  Google Scholar 

  47. Goldenberg-Cohen N, Bahar I, Ostashinski M, et al (2005) Cyclocryotherapy versus transscleral diode laser cyclophotocoagulation for uncontrolled intraocular pressure. Ophthalmic Surg Lasers Imaging 36:272–279.

    PubMed  Google Scholar 

  48. Hennekes R, Belgrado G (1992) Cyclocryotherapy as an alternative treatment for primary glaucoma. Bull Soc Belge Ophtalmol 244:169–176.

    PubMed  CAS  Google Scholar 

  49. Edmunds B, Thompson JR, Salmon JF, et al (2002) The National Survey of Trabeculectomy. III. Early and late complications. Eye 16:297–303.

    Article  PubMed  CAS  Google Scholar 

  50. Coleman AL, Hill R, Wilson MR, et al (1995) Initial clinical experience with the Ahmed glaucoma valve implant. Am J Ophthalmol 120:23–31. Erratum in: Am J Ophthalmol (1995) 120:684.

    PubMed  CAS  Google Scholar 

  51. Topouzis F, Coleman AL, Choplin N, et al (1999) Follow-up of the original cohort with the Ahmed glaucoma valve implant. Am J Ophthalmol 128:198–204.

    Article  PubMed  CAS  Google Scholar 

  52. Wilson MR, Mendis U, Paliwal A, et al (2003) Long-term follow-up of primary glaucoma surgery with Ahmed glaucoma valve implant versus trabeculectomy. Am J Ophthalmol 136:464–470.

    Article  PubMed  Google Scholar 

  53. Jampel HD, Musch DC, Gillespie BW; Collaborative Initial Glaucoma Treatment Study Group. (2005) Perioperative complications of trabeculectomy in the collaborative initial glaucoma treatment study (CIGTS). Am J Ophthalmol 140:16–22.

    Google Scholar 

  54. Lamping KA, Bellows AR, Hutchinson BT, et al (1986) Long-term evaluation of initial filtration surgery. Ophthal­mology 93:91–101.

    CAS  Google Scholar 

  55. Parc CE, Johnson DH, Oliver JE, et al (2001) The long-term outcome of glaucoma filtration surgery. Am J Ophthalmol 132:27–35.

    Article  PubMed  CAS  Google Scholar 

  56. Ehrnrooth P, Puska P, Lehto I, et al (2005) Progression of visual field defects and visual loss in trabeculectomized eyes. Graefes Arch Clin Exp Ophthalmol 243:741–747.

    Article  PubMed  Google Scholar 

  57. AGIS (Advanced Glaucoma Intervention Study) Investigators (2001) The Advanced Glaucoma Intervention Study 8: risk of cataract formation after trabeculectomy. Arch Ophthalmol 119:1771–1779.

    Google Scholar 

  58. Aggarwal SP, Hendeles S (1986) Risk of sudden visual loss following trabeculectomy in advanced primary open-angle glaucoma. Br J Ophthalmol 70:97–99.

    Article  PubMed  CAS  Google Scholar 

  59. Kolker AE (1977) Visual prognosis in advanced glaucoma: a comparison of medical and surgical therapy for retention of vision in 101 eyes with advanced glaucoma. Trans Am Ophthalmol Soc 75:539–555.

    PubMed  CAS  Google Scholar 

  60. Otto J (1957) Loss of point of fixation after glaucoma surgery. Klin Monatsbl Augenheilkd 131:178–195.

    CAS  Google Scholar 

  61. Costa VP, Smith M, Spaeth GL, et al (1993) Loss of visual acuity after trabeculectomy. Ophthalmology 100:599–612.

    PubMed  CAS  Google Scholar 

  62. Lichter PR, Ravin JG (1974) Risks of sudden visual loss after glaucoma surgery. Am J Ophthalmol 78:1009–1013.

    PubMed  CAS  Google Scholar 

  63. O’Connell EJ, Karseras AG (1976) Intraocular surgery in advanced glaucoma. Br J Ophthalmol 60:124–131.

    Article  PubMed  Google Scholar 

  64. Martinez JA, Brown RH, Lynch MG, et al (1993) Risk of postoperative visual loss in advanced glaucoma. Am J Ophthalmol 115:332–337.

    PubMed  CAS  Google Scholar 

  65. Topouzis F, Tranos P, Koskosas A, et al (2005) Risk of sudden visual loss following filtration surgery in end-stage glaucoma. Am J Ophthalmol 140:661–666.

    Article  PubMed  Google Scholar 

  66. Levene RZ (1992) Central visual field, visual acuity, and sudden visual loss after glaucoma surgery. Ophthalmic Surg 23:388–394.

    PubMed  CAS  Google Scholar 

  67. Langerhorst CT, de Clercq B, van den Berg TJ (1990) Visual field behavior after intra-ocular surgery in glaucoma patients with advanced defects. Doc Ophthalmol 75:281–289.

    Article  PubMed  CAS  Google Scholar 

  68. Awai M, Koga T, Inatani M, et al (2007) Stability of the central visual field after modern trabeculectomy techniques in eyes with advanced glaucoma. Jpn J Ophthalmol 51:116–120.

    Article  PubMed  Google Scholar 

  69. Lüke C, Dietlein TS, Jacobi PC, et al (2002) A prospective randomized trial of viscocanalostomy versus trabeculectomy in open-angle glaucoma: a 1-year follow-up study. J Glau­coma 11:294–299.

    Article  Google Scholar 

  70. Cillino S, Di Pace F, Casuccio A, et al (2004) Deep sclerectomy versus punch trabeculectomy with and without phacoemulsification: a randomised clinical trial. J Glaucoma 13:500–506.

    Article  PubMed  Google Scholar 

  71. Yarangumeli A, Gureser S, Gurbuz Koz O, et al (2004) Viscocanalostomy versus trabeculectomy in patients with bilateral high-tension glaucoma. Int Ophthalmol 25:207–213.

    Article  PubMed  Google Scholar 

  72. Yalvac IS, Sahin M, Eksioglu U, et al (2004) Primary viscocanalostomy versus trabeculectomy for primary open-angle glaucoma: three-year prospective randomised clinical trial. J Cataract Refract Surg 30:2050–2057.

    Article  PubMed  Google Scholar 

  73. O’Brart DPS, Shiew M, Edmunds B, et al (2004) A randomised, prospective study comparing trabeculectomy with viscocanalostomy with adjunctive antimetabolite usage for the management of open angle glaucoma uncontrolled by medical therapy. Br J Ophthalmol 88:1012–1017.

    Article  PubMed  Google Scholar 

  74. Carassa RG, Bettin P, Fiori M, et al (2003) Viscocanalostomy versus trabeculectomy in whit adults affected by open-angle glaucoma: a 2-year randomised controlled trial. Ophthal­mology 110:882–887.

    Article  Google Scholar 

  75. Kobayashi H, Kobayashi K, Okinami S (2003) A comparison of the intraocular pressure-lowering effect and safety of viscocanalostomy and trabeculectomy with mitomycin C in bilateral open angle glaucoma. Graefe’s Arch Clin Exp Ophthalmol 241:359–366.

    Article  CAS  Google Scholar 

  76. Chiselita D (2001) Nonpenetrating deep sclerectomy versus trabeculectomy in primary open-angle glaucoma surgery. Eye 15:197–201.

    Article  PubMed  CAS  Google Scholar 

  77. El Sayyad F, Helal M, El-Kholify H, et al (2000) Nonpenetrating deep sclerectomy versus trabeculectomy in bilateral primary open-angle glaucoma. Ophthalmology 107:1671–1674.

    Article  PubMed  CAS  Google Scholar 

  78. Ambresin A, Shaarawy T, Mermoud A (2002) Deep sclerectomy with collagen implant in one eye compared with trabeculectomy in the other eye of the same patient. J Glaucoma 11:214–220.

    Article  PubMed  Google Scholar 

  79. Anand N, Atherley C (2005) Deep sclerectomy augmented with mitomycin C. Eye 19:442–450.

    Article  PubMed  CAS  Google Scholar 

  80. Caprioli J, Strang SL, Spaeth GL, et al (1985) Cyclocry­otherapy in the treatment of advanced glaucoma. Ophthal­mology 92:947–954.

    CAS  Google Scholar 

  81. Benson MT, Nelson ME (1990) Cyclocryotherapy: a review of cases over a 10-year period. Br J Ophthalmol 74:103–105.

    Article  PubMed  CAS  Google Scholar 

  82. Brindley G, Shields MB (1986) Value and limitations of cyclocryotherapy. Graefes Arch Clin Exp Ophthalmol 224: 545–548.

    Article  PubMed  CAS  Google Scholar 

  83. Nicaeus T, Derse M, Schlote T, et al (1999) Die Zyk­lokryokoagulation in der Behandlung therapierefraktärer Glaukome: Eine retrospektive Analyse von 185 Zyklokryokoag­ulationen. Klin Monatsbl Augenheilkd 214:224–230.

    Article  PubMed  CAS  Google Scholar 

  84. Schlote T, Derse M, Rassmann K, et al (2001) Efficacy and safety of contact transscleral diode laser cyclophotocoagulation for advanced glaucoma. J Glaucoma 10:294–301.

    Article  PubMed  CAS  Google Scholar 

  85. Costa VP, Moster MR, Wilson RP, et al (1993) Effects of topical mitomycin C on primary trabeculectomies and combined procedures. Br J Ophthalmol 77:693–697.

    Article  PubMed  CAS  Google Scholar 

  86. Shields MB, Scroggs MW, Sloop CM, et al (1993) Clinical and histopathologic observations concerning hypotony after trabeculectomy with adjunctive mitomycin C. Am J Ophthal­mol 116:673–683.

    CAS  Google Scholar 

  87. Kitazawa Y, Suemori-Matsushita H, Yamamoto T, et al (1993) Low-dose and high-dose mitomycin trabeculectomy as an initial surgery in primary open-angle glaucoma. Ophthal­mology 100:1624–1628.

    CAS  Google Scholar 

  88. Mégevand GS, Salmon JF, Scholtz RP, et al (1995) The effect of reduci.ng the exposure time of mitomycin C in glaucoma filtering surgery. Ophthalmology 102:84–90.

    PubMed  Google Scholar 

  89. Cheung JC, Wright MM, Murali S, et al (1997) Intermediate-term outcome of variable dose mitomycin C filtering surgery. Ophthalmology 104:143–149.

    Article  PubMed  CAS  Google Scholar 

  90. Perkins TW, Gangnon R, Ladd W, Kaufman PL, Heatley GA (1998) Trabeculectomy with mitomycin C: intermediate-term results. J Glaucoma 7:230–236.

    PubMed  CAS  Google Scholar 

  91. Rasheed el-S (1999) Initial trabeculectomy with intraoperative mitomycin-C application in primary glaucomas. Ophthalmic Surg Lasers 30:360–366.

    Google Scholar 

  92. Mietz H, Krieglstein GK (2001) Suramin to enhance glaucoma filtering procedures: a clinical comparison with mitomycin. Ophthalmic Surg Lasers 32:358–369.

    PubMed  CAS  Google Scholar 

  93. Mietz H, Jacobi PC, Krieglstein GK (2002) Intraoperative episcleral versus postoperative topical application of mitomycin-C for trabeculectomies. Ophthalmology 109: 1343–1349.

    Article  PubMed  Google Scholar 

  94. Tsai JC, Chang HW, Kao CN, Lai IC, Teng MC (2003) Trabeculectomy with mitomycin C versus trabeculectomy alone for juvenile primary open-angle glaucoma. Ophthal­mologica 217:24–30.

    Article  Google Scholar 

  95. Fontana H, Nouri-Mahdavi K, Lumba J, et al (2006) Trabeculectomy with mitomycin C: outcomes and risk factors for failure in phakic open-angle glaucoma. Ophthal­mology 113:930–936.

    Article  Google Scholar 

  96. Shigeeda T, Tomidokoro A, Chen YN, et al (2006) Long-term follow-up of initial trabeculectomy with mitomycin C for primary open-angle glaucoma in Japanese patients. J Glaucoma 15:195–199.

    Article  PubMed  Google Scholar 

  97. Ehrnrooth P, Lehto I, Puska P, et al (2003) Effects of early postoperative complications and the location of trephined block on long-term intraocular pressure control after trabeculectomy. Graefes Arch Clin Exp Ophthalmol 24: 803–808.

    Article  Google Scholar 

  98. Quigley HA (1997) Reappraising the risk and benefits of aggressive glaucoma therapy. Ophthalmology 104: 1985–1986.

    Article  PubMed  CAS  Google Scholar 

  99. Song A, Scott IU, Flynn HW Jr, et al (2002) Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes. Ophthalmology 109:985–991.

    Article  PubMed  Google Scholar 

  100. Soltau JB, Rothman RF, Budenz DL, et al (2000) Risk factors for glaucoma filtering bleb infections. Arch Ophthalmol 118:338–342.

    PubMed  CAS  Google Scholar 

  101. Higginbotham EJ, Stevens RK, Musch DC, et al (1996) Bleb-related endophthalmitis after trabeculectomy with mitomycin C. Ophthalmology 103:650–656.

    PubMed  CAS  Google Scholar 

  102. Susanna R Jr, Takahashi W, Nicolela M (1996) Late bleb leakage after trabeculectomy with 5-fluorouracil or mitomycin C. Can J Ophthalmol 31:296–300.

    PubMed  Google Scholar 

  103. Greenfield DS, Suner IJ, Miller MP, et al (1996) Endophthalmitis after filtering surgery with mitomycin. Arch Ophthalmol 114:943–949.

    Article  PubMed  CAS  Google Scholar 

  104. Mietz H, Arnold G, Kirchhof B, et al (1996) Histopathology of episcleral fibrosis after trabeculectomy with and without mitomycin C. Graefes Arch Clin Exp Ophthalmol 234: 364–368.

    Article  PubMed  CAS  Google Scholar 

  105. Mietz H, Brunner R, Addicks K, et al (1993) Histopathology of an avascular filtering bleb after trabeculectomy with mitomycin C. J Glaucoma 93:266–270.

    Google Scholar 

  106. Moster MR, Moster ML (2005) Wipe-out: a complication of glaucoma surgery or just a blast from the past? Am J Ophthalmol 140:705–706.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. A’ Department of Ophthalmology, Aristotle University of Thessaloniki, AHEPA Hospital, Stilponos Kyriakidi 1, 54636, Nea Efkarpia, Thessaloniki, 56403, Greece

    Fotis Topouzis

Authors
  1. Fotis Topouzis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fotis Topouzis .

Editor information

Editors and Affiliations

  1. Jules Stein Eye Institute, Stein Plaza 100, Los Angeles, 90095, U.S.A.

    JoAnn A. Giaconi

  2. Jules Stein Eye Institute, Stein Plaza 100, Los Angeles, 90095, U.S.A.

    Simon K. Law

  3. Jules Stein Eye Institute, Stein Plaza 100, Los Angeles, 90095, U.S.A.

    Anne L. Coleman

  4. Jules Stein Eye Institute, Stein Plaza 100, Los Angeles, 90095, U.S.A.

    Joseph Caprioli

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Topouzis, F. (2010). Procedural Treatments: Surgery in End-Stage Glaucoma. In: Giaconi, J., Law, S., Coleman, A., Caprioli, J. (eds) Pearls of Glaucoma Management. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-68240-0_42

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-68240-0_42

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-68238-7

  • Online ISBN: 978-3-540-68240-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation